Covered recipient · General Payments record
CHERYL A MCGARRY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2023
$3,843.69
- Reported across 234 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $740.32 | 36 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $215.84 | 18 |
| EMD Serono, Inc. | $174.21 | 8 |
| Biogen, Inc. | $171.39 | 2 |
| Teva Pharmaceuticals USA, Inc. | $56.35 | 3 |
| TG THERAPEUTICS, INC. | $49.21 | 2 |
| ARGENX US, INC. | $39.24 | 1 |
| Inspire Medical Systems, Inc. | $17.89 | 1 |
| Genentech USA, Inc. | $16.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.70 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137943 | CMS |
| ABBVIE INC. | $10.42 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137947 | CMS |
| ABBVIE INC. | $14.44 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137951 | CMS |
| ABBVIE INC. | $10.42 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137957 | CMS |
| ABBVIE INC. | $20.00 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137961 | CMS |
| ABBVIE INC. | $4.61 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137967 | CMS |
| ABBVIE INC. | $5.55 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137971 | CMS |
| ABBVIE INC. | $11.60 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137977 | CMS |
| ABBVIE INC. | $6.28 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137981 | CMS |
| ABBVIE INC. | $18.57 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137987 | CMS |
| ABBVIE INC. | $15.29 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137991 | CMS |
| ABBVIE INC. | $24.82 | 04/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006137997 | CMS |
| ABBVIE INC. | $6.40 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006138001 | CMS |
| ABBVIE INC. | $13.69 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006138007 | CMS |
| ABBVIE INC. | $26.32 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006138011 | CMS |
| ABBVIE INC. | $5.38 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006138015 | CMS |
| ABBVIE INC. | $6.37 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006138021 | CMS |
| ABBVIE INC. | $4.98 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006138025 | CMS |
| ARGENX US, INC. | $39.24 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060420213 | CMS |
| Biogen, Inc. | $73.36 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012185651 | CMS |
| Biogen, Inc. | $98.03 | 04/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012226899 | CMS |
| EMD Serono, Inc. | $2.71 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032428971 | CMS |
| EMD Serono, Inc. | $29.86 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032430739 | CMS |
| EMD Serono, Inc. | $0.55 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032428473 | CMS |
| EMD Serono, Inc. | $26.18 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032449523 | CMS |
| EMD Serono, Inc. | $25.03 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032483703 | CMS |
| EMD Serono, Inc. | $34.65 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032499132 | CMS |
| EMD Serono, Inc. | $25.40 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032342775 | CMS |
| EMD Serono, Inc. | $29.83 | 07/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032306105 | CMS |
| Genentech USA, Inc. | $16.19 | 04/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040627603 | CMS |
| Inspire Medical Systems, Inc. | $17.89 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1058917537 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.33 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056819049 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.78 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056819079 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.24 | 05/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056819123 | CMS |
| TG Therapeutics, Inc. | $24.71 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051500237 | CMS |
| TG Therapeutics, Inc. | $24.50 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051500301 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.